National Health Investors Q4 2023 FFO $1.09 Beats $1.07 Estimate, Sales $79.47M Beat $78.44M Estimate
Portfolio Pulse from Benzinga Newsdesk
National Health Investors (NHI) reported Q4 2023 earnings of $1.09 per share, surpassing the $1.07 estimate. Sales reached $79.47M, exceeding the $78.44M forecast, marking a 12.45% increase from the previous year.
February 20, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NHI reported Q4 2023 earnings of $1.09 per share, beating estimates, with sales of $79.47M also surpassing forecasts.
NHI's earnings and sales beat not only demonstrates the company's ability to surpass analyst expectations but also indicates a significant year-over-year growth in sales. This positive performance is likely to instill investor confidence and could lead to a short-term uptick in NHI's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100